Speaker: Professor Snow Stolnik, Director of EPSRC Centre for Doctoral Training in Transformative Pharmaceutical Technologies, Faculty of Science
New drug molecules, arising from advances in drug discovery and biotechnology, offer the potential to redefine the treatments of degenerative, genetic, autoimmune diseases, or cancer - if their delivery challenges can be addressed. New pharmaceutical solutions are needed to transport these drug molecules across formidable biological barriers of the body and deliver them at desired locations in target tissue, or individual cell, where they need to act. In this lecture, I will review my work at interfaces of different science disciplines that aim to understand how advanced pharmaceutical formulations could be designed to translate new drug molecules into future medicines.
Snow Stolnik received her Dipl. Eng. degree in Pharmacy from the University of Zagreb, Croatia, and conducted research for her masters and PhD theses at McGill University, Canada and at the School of Pharmacy, University of Nottingham, respectively. She is currently Director of EPSRC Centre for Doctoral Training in Transformative Pharmaceutical Technologies at the University of Nottingham, University College London, SSPC Centre for Pharmaceuticals in Ireland and a consortium of pharmaceutical and healthcare industry partners. Her research lies at the interface of a design of drug delivery formulations, their characterisation and understanding of their biological performances.